Comparison The Effect of Ventolin Nebulizer With And Without Hypertonic Saline% 3 On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease

Comparison The Effect of Ventolin Nebulizer With And Without Hypertonic Saline % 3 On Dyspnea In Patients With Chronic Obstructive Pulmonary Disease

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181205041858N1

Enrollment

Registered

2019-10-16

Start date

2019-01-26

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease. Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention 1: The intervention group will receive Ventolin plus 5 cc hypertonic saline 3% at intervals of 6 hours as a nebulizer .hypertonic saline 3% at intervals of 6 hours as a nebulizer. Interve

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: Participate in research. Be alert Be known to be COPD or hospitalized with this diagnosis Have moderate or high dyspnea (at least scale 3 of the bourgeois scale) Nebulizer Ventolin in patient medication orders which have been ordered by a Internal specialist.

Exclusion criteria

Exclusion criteria: Patient's death or decreased level of consciousness during treatment After diagnosis, the patient's shortness of breath is due to myocardial infarction, myocardial infarction, or congestive heart failure. Patient's unwillingness to continue research

Design outcomes

Primary

Measure	Time frame
Dyspnea. Timepoint: Before and 24, 48 hours after intervention. Method of measurement: Borg scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzam Razizadeh

Gonabad University of Medical Sciences

razizadeh.a@gmu.ac.ir+98 51 5722 5027

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026